NBSE Past Earnings image   This NBSE past earnings page last updated 2/16/2023
NBSE Past Earnings
PeriodPast Earnings DateGAAP
Q1 20232/14/2023-0.130
Q4 202212/21/2022-0.240
Q3 20228/11/2022-0.260
Q2 20225/12/2022-0.300
Q3 20218/12/2021-0.290
Q2 20215/13/2021-0.240
Q1 20212/11/2021-0.180
Q3 20208/13/2020-0.180
Q2 20205/14/2020-0.260
Q1 20203/26/2020-0.260
FY 20191/9/2020-0.450
Q3 20198/14/2019-0.400
NBSE Past Revenue
PeriodPast Earnings DateGAAP
Q1 20232/14/2023NA
Q4 202212/21/2022NA
Q3 20228/11/2022NA
Q2 20225/12/2022NA
Q3 20218/12/2021NA
Q2 20215/13/2021NA
Q1 20212/11/2021NA
Q3 20208/13/2020NA
Q2 20205/14/2020NA
Q1 20203/26/2020NA
FY 20191/9/2020NA
Q3 20198/14/2019NA
Quotes delayed 20 minutes

Email EnvelopeFree NBSE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NeuBase Therapeutics (NBSE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NDRA Past Earnings
NEO Past Earnings
NEOG Past Earnings
NERV Past Earnings
NEXI Past Earnings
NGM Past Earnings
NKTR Past Earnings
NKTX Past Earnings
NLTX Past Earnings
NMTC Past Earnings

NBSE Past Earnings Q&A

What was the best and worst NBSE past earnings results?
For NeuBase Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NBSE past earnings result in our data set was -0.130/share posted in Q1 2023, while the lowest was in FY 2019 when NBSE posted -0.450/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2023 when NBSE reported NA in revenue, while the quarter with the lowest revenue in our data set was Q1 2023 at NA of revenue.

  Suggested answer: There are 12 NBSE past earnings results in our data set.

On this page we presented the NBSE past earnings date information for NeuBase Therapeutics. Reviewing that NBSE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2023, when NBSE posted gaap of -0.130/share. Meanwhile the lowest NBSE past earnings result was in FY 2019, when NBSE posted gaap of -0.450/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2023 when NBSE reported NA in revenue, while the smallest revenue quarter was Q1 2023 when NBSE reported NA in revenue.

Any self directed investor doing their due diligence on NBSE or any other given stock can benefit from researching all of the NeuBase Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate NeuBase Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NBSE. Thanks for visiting, and the next time you need to research NBSE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding VSPY, Top Ten Hedge Funds Holding ONTL, HDB Historical Stock Prices.


NBSE Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.